Q4 2024 |
227 |
$4.3B |
+$1.23B |
-$741M |
+$486M |
PTCT, SUPN, TVTX, INCY, NBIX
|
13F-HR |
2/14/2025, 03:15 PM |
Q3 2024 |
254 |
$3.82B |
+$715M |
-$902M |
-$187M |
PTCT, SUPN, INCY, TVTX, IMVT
|
13F-HR |
11/14/2024, 11:13 AM |
Q2 2024 |
250 |
$3.82B |
+$1.03B |
-$715M |
+$315M |
PTCT, SUPN, NBIX, CYTK, INCY
|
13F-HR |
8/14/2024, 02:38 PM |
Q1 2024 |
323 |
$3.74B |
+$1.12B |
-$1.38B |
-$264M |
PTCT, NBIX, INCY, SUPN, CYTK
|
13F-HR |
5/15/2024, 02:21 PM |
Q4 2023 |
281 |
$7.32B |
+$985M |
-$1.02B |
-$33.5M |
PTCT, NBIX, SUPN, ARGX, AUPH
|
13F-HR |
2/13/2024, 04:57 PM |
Q3 2023 |
300 |
$6.52B |
+$1.06B |
-$960M |
+$102M |
SPY, IWM, SUPN, PTCT, NBIX
|
13F-HR |
11/14/2023, 01:07 PM |
Q2 2023 |
290 |
$6.91B |
+$1.08B |
-$1.31B |
-$234M |
SPY, IWM, NBIX, SUPN, MRTX
|
13F-HR |
8/14/2023, 03:12 PM |
Q1 2023 |
225 |
$6.94B |
+$1.69B |
-$450M |
+$1.24B |
SPY, IWM, NBIX, TVTX, SUPN
|
13F-HR |
5/15/2023, 01:21 PM |
Q4 2022 |
191 |
$5.73B |
+$1.08B |
-$1.19B |
-$108M |
SPY, IWM, MRTX, SUPN, TVTX
|
13F-HR |
2/14/2023, 01:06 PM |
Q3 2022 |
191 |
$5.75B |
+$3.02B |
-$402M |
+$2.62B |
SPY, IWM, INCY, SUPN, PTCT
|
13F-HR |
11/14/2022, 04:15 PM |
Q2 2022 |
174 |
$3.9B |
+$1.62B |
-$257M |
+$1.36B |
INCY, MRTX, SUPN, PTCT, NBIX
|
13F-HR |
8/15/2022, 03:34 PM |
Q1 2022 |
138 |
$5.17B |
+$1.27B |
-$791M |
+$483M |
SPY, IWM, TVTX, INCY, BIIB
|
13F-HR |
5/16/2022, 03:20 PM |
Q4 2021 |
145 |
$6.11B |
+$1.31B |
-$488M |
+$820M |
SPY, IWM, INCY, BMY, TVTX
|
13F-HR |
2/14/2022, 03:33 PM |
Q3 2021 |
135 |
$4.05B |
+$1.35B |
-$928M |
+$424M |
INCY, BMY, MRTX, VRTX, TVTX
|
13F-HR |
11/15/2021, 02:44 PM |
Q2 2021 |
113 |
$3.77B |
+$1.24B |
-$788M |
+$456M |
CERC, BIIB, VRTX, BMY, MRTX
|
13F-HR |
8/16/2021, 03:51 PM |
Q1 2021 |
109 |
$3.12B |
+$1.42B |
-$599M |
+$816M |
CERC, BMY, MRTX, SUPN, VRTX
|
13F-HR |
5/17/2021, 01:38 PM |
Q4 2020 |
2 |
$705K |
|
|
|
SPY, IWM
|
New Holdings |
3/4/2021, 02:15 PM |
Q4 2020 |
105 |
$2.23B |
+$695M |
-$346M |
+$349M |
CERC, SUPN, VNDA, LNTH, BMY
|
13F-HR |
2/16/2021, 02:14 PM |
Q3 2020 |
101 |
$2.76B |
+$997M |
-$205M |
+$792M |
SPY, IWM, CERC, SUPN, ENR
|
13F-HR |
11/16/2020, 02:21 PM |
Q2 2020 |
78 |
$2.28B |
+$716M |
-$437M |
+$280M |
SPY, IWM, CERC, UNH, BMY
|
13F-HR |
8/14/2020, 03:27 PM |
Q1 2020 |
77 |
$1.6B |
+$734M |
-$147M |
+$587M |
SPY, IWM, CERC, SUPN, VNDA
|
13F-HR |
5/15/2020, 02:19 PM |
Q4 2019 |
69 |
$1.72B |
+$709M |
-$257M |
+$452M |
IWM, SPY, CERC, AMAG, EPC
|
13F-HR |
2/14/2020, 01:55 PM |
Q3 2019 |
61 |
$1.49B |
+$641M |
-$45.9B |
-$45.3B |
SPY, IWM, CERC, CELG, EPC
|
13F-HR |
11/14/2019, 01:33 PM |
Q2 2019 |
60 |
$1.58B |
+$479M |
-$211M |
+$267M |
SPY, CERC, ENR, DFRG, VNDA
|
13F-HR |
8/14/2019, 03:41 PM |
Q1 2019 |
69 |
$1.83B |
+$685M |
-$176M |
+$509M |
SPY, CERC, CVS, ENR, CELG
|
13F-HR |
5/15/2019, 03:39 PM |
Q4 2018 |
70 |
$1.32B |
+$674M |
-$33.8M |
+$640M |
SPY, CLVSQ, CERC, ENR, PLYA
|
13F-HR |
2/14/2019, 12:43 PM |
Q3 2018 |
76 |
$1.67B |
+$656M |
-$218M |
+$438M |
SPY, CERC, CPB, CAKE, HAIN
|
13F-HR |
11/14/2018, 01:24 PM |
Q2 2018 |
73 |
$1.53B |
+$678M |
-$86.4M |
+$591M |
SPY, CERC, EPC, MNKKQ, REGN
|
13F-HR |
8/14/2018, 01:44 PM |
Q1 2018 |
64 |
$1.24B |
+$541M |
-$6.67M |
+$535M |
SPY, VNDA, UTHR, FRPT, AMAG
|
13F-HR |
5/15/2018, 03:55 PM |
Q4 2017 |
66 |
$1B |
+$406M |
-$45.6M |
+$361M |
SPY, CERC, HAIN, VNDA, UTHR
|
Restatement |
2/14/2018, 11:16 AM |
Q3 2017 |
63 |
$845M |
+$331M |
-$74M |
+$257M |
SPY, HAIN, DECK, VNDA, DEPO
|
13F-HR |
11/14/2017, 01:45 PM |
Q2 2017 |
59 |
$785M |
+$371M |
-$30.5M |
+$341M |
SPY, VNDA, DECK, DEPO, HAIN
|
13F-HR |
8/14/2017, 10:13 AM |
Q1 2017 |
47 |
$484M |
+$267M |
-$23.2M |
+$244M |
SPY, ATRS, VNDA, WFM, NVLNF
|
13F-HR |
5/15/2017, 10:07 AM |
Q4 2016 |
48 |
$423M |
+$207M |
-$9.14M |
+$198M |
ATRS, HAIN, FRPT, PCRX, LVS
|
13F-HR |
2/14/2017, 05:17 PM |
Q3 2016 |
42 |
$309M |
+$124M |
-$28.1M |
+$96.4M |
ATRS, HAIN, ACOR, ARLZ, RXDX
|
13F-HR |
11/14/2016, 04:30 PM |
Q2 2016 |
45 |
$262M |
+$114M |
-$64.5M |
+$49.5M |
ATRS, VNDA, ARLZ, TLRDQ, RXDX
|
13F-HR |
8/15/2016, 03:58 PM |
Q1 2016 |
33 |
$254M |
+$105M |
-$18.1M |
+$86.9M |
ATRS, VNDA, XNPT, RXDX, FRPT
|
Restatement |
5/16/2016, 02:31 PM |
Q4 2015 |
31 |
$266M |
+$138M |
-$22.1M |
+$116M |
ATRS, VNDA, FRPT, RXDX, BDSI
|
13F-HR |
2/16/2016, 12:28 PM |
Q3 2015 |
37 |
$275M |
+$168M |
-$30.4M |
+$138M |
GSKXXXX, PTX, ATRS, KODK, FRPT
|
13F-HR |
11/16/2015, 12:38 PM |
Q2 2015 |
28 |
$278M |
+$137M |
-$30.5M |
+$107M |
SPY, SPPI, APOL, KODK, VNDA
|
13F-HR |
8/14/2015, 02:11 PM |
Q1 2015 |
27 |
$226M |
+$117M |
-$12.4M |
+$104M |
SPY, VNDA, RXDX, SPPI, KODK
|
13F-HR |
5/15/2015, 10:11 AM |
Q4 2014 |
29 |
$208M |
|
|
|
SPPI, ZGNXXXXX, VNDA, HPTX, RXDX
|
13F-HR |
2/17/2015, 02:04 PM |